이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Sofiva GenomicsLtd 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	no data
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	데이터 없음

최근 관리 업데이트

Recent updates

Some Investors May Be Worried About Sofiva GenomicsLtd's (GTSM:6615) Returns On Capital

Apr 14

Estimating The Fair Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)

Mar 18

Sofiva Genomics Co.,Ltd. (GTSM:6615) Investors Should Think About This Before Buying It For Its Dividend

Feb 24

Should Weakness in Sofiva Genomics Co.,Ltd.'s (GTSM:6615) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Jan 27

CEO

Sofiva GenomicsLtd 에는 CEO가 없거나 그에 대한 데이터가 없습니다.

Sofiva GenomicsLtd 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

Sofiva Genomics Co.,Ltd., Annual General Meeting, May 29, 2024

Sofiva Genomics Co.,Ltd. Announces Resignation of Su,Yining as CEO

Sofiva Genomics Co.,Ltd. Announces Resignation of Su,Yining as CEO

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Second quarter 2024 earnings released: EPS: NT$0.45 (vs NT$0.20 in 2Q 2023)

Sofiva Genomics Co.,Ltd. to Report Q2, 2024 Results on Aug 14, 2024

Investor sentiment deteriorates as stock falls 21%

Investor sentiment improves as stock rises 17%

Upcoming dividend of NT$0.20 per share

Dividend reduced to NT$0.20

New major risk - Share price stability

Investor sentiment improves as stock rises 16%

First quarter 2024 earnings released: EPS: NT$0.58 (vs NT$0.20 in 1Q 2023)

Sofiva Genomics Co.,Ltd. to Report Q1, 2024 Results on May 15, 2024

New minor risk - Profit margin trend

Sofiva Genomics Co.,Ltd., Annual General Meeting, May 29, 2024

Third quarter 2023 earnings released: EPS: NT$0.27 (vs NT$0.12 in 3Q 2022)

Sofiva Genomics Co.,Ltd. Announces Resignation of Su,Yining as CEO

Sofiva Genomics Co.,Ltd. Announces Resignation of Su,Yining as CEO

Second quarter 2023 earnings released: EPS: NT$0.20 (vs NT$0.28 in 2Q 2022)

Investor sentiment improves as stock rises 18%

Upcoming dividend of NT$1.00 per share at 2.5% yield

Sofiva Genomics Co.,Ltd. Declares Cash Dividend, Payable on July 31, 2023

Investor sentiment improves as stock rises 23%

Full year 2022 earnings released: EPS: NT$2.00 (vs NT$2.68 in FY 2021)

Less than half of directors are independent

Second quarter 2022 earnings: EPS misses analyst expectations

Upcoming dividend of NT$2.00 per share

Sofiva Genomics Co.,Ltd. Announces Cash Dividend, Payable on July 28, 2022

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Less than half of directors are independent

Third quarter 2021 earnings released: EPS NT$0.68 (vs NT$0.28 in 3Q 2020)

Second quarter 2021 earnings released: EPS NT$0.93 (vs NT$0.40 in 2Q 2020)

Upcoming dividend of NT$1.40 per share

First quarter 2021 earnings released: EPS NT$0.42 (vs NT$0.49 in 1Q 2020)

First quarter 2021 earnings released: EPS NT$0.42 (vs NT$0.49 in 1Q 2020)

Investor sentiment improved over the past week

Some Investors May Be Worried About Sofiva GenomicsLtd's (GTSM:6615) Returns On Capital

Full year 2020 earnings released: EPS NT$1.63 (vs NT$2.96 in FY 2019)

Estimating The Fair Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)

Sofiva Genomics Co.,Ltd. (GTSM:6615) Investors Should Think About This Before Buying It For Its Dividend

Should Weakness in Sofiva Genomics Co.,Ltd.'s (GTSM:6615) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

New 90-day low: NT$50.60

Our Take On The Returns On Capital At Sofiva GenomicsLtd (GTSM:6615)

New 90-day low: NT$51.60

A Look At The Intrinsic Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)

New 90-day low: NT$54.00

Read This Before Buying Sofiva Genomics Co.,Ltd. (GTSM:6615) For Its Dividend

Third quarter 2020 earnings released: EPS NT$0.28

New 90-day low: NT$55.00

New 90-day low - NT$55.20

New 90-day low - NT$59.00

First half earnings released

CEO